⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for low dose cyclophosphamide (ctx) daily

Every month we try and update this database with for low dose cyclophosphamide (ctx) daily cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDSNCT03417154
Acute Myeloid L...
Higher Risk Mye...
Nivolumab
Low dose Cyclop...
Low dose Cyclop...
18 Years - Masonic Cancer Center, University of Minnesota
Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDSNCT03417154
Acute Myeloid L...
Higher Risk Mye...
Nivolumab
Low dose Cyclop...
Low dose Cyclop...
18 Years - Masonic Cancer Center, University of Minnesota
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: